iStock Rating

D
Details...
Enter Symbol click to research

China Medical Technologies, Inc. (NASDAQ: CMED)

Sector: Medical

Current Price : $1.82

52 Week Low
$1.82
52 Week High
$13.42
 

CHINA MED(NSDQ:CMED)
China Medical Technologies, Inc. is a China-based medical device company that develops, manufactures and markets products using HIFU for the treatment of solid cancers and benign tumors in China. They design and development HIFU tumor therapy devices in China. Their HIFU therapy system is SFDA-approved and has been used to treat over 20,000 patient cases. In addition, they offer an integrated luminescence immunoassay IVD system using ECLIA technology to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood or urine.
# Employees: 971
Address: NO.24 YONG CHANG NORTH ROAD BEIJING ECONOMIC-TECH,DEVELOPMENT AREA BEIJING,F4,CHN
Phone: (86-10) 6787 1166
Fax: 86 10 6788 9588
Website: http://www.chinameditech.com
Email: ir@chinameditech.com
Sector: Medical
Industry: MED PRODUCTS
Executive Officers
Xiaodong Wu (Chairman; chief executive officer)
Takyung (Sam) Tsang (chief financial officer)
Lawrence A. Crum (director)
Yuedong Li (director)
Guoming Qi (director,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2011
Next Earnings Date(Expected): 2/23/2012
Mean EPS (Next Qtr): $0.50
Mean EPS (Year): $2.03
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): 0.900
Number of Estimates: 1
Shares Performance
Period cmed Compare to S&P
YTD -35.92 % -40.79 %
4 Weeks -50.41 % -52.13 %
12 Weeks -46.78 % -51.51 %
Shares Information
Analyst Coverage: Y
Avg Volume: 585803
Shares Outstanding: 32M
Market Cap: $0.06B
52 Week High: $13.42
52 Week Low: $1.82
P/E Ratio: 1.150
PEG Ratio: -0.010
Split: On 1/1/1990 cmed split by factor of 0.170
Earnings Performance
EPS Growth in Last Quarter: 2.04 %
EPS Growth in Last Year: 85.19 %
Sales Growth in Last Quarter: 1.91 %
Sales Growth in Last Quarter: 23.93 %
Financials
Qtr Book Value: $0.20
Cash Flow/Share: $5.72
Change in Payout Ratio: -0.010
Price/Sales: -0.010
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.